HAE vs LIVN Stock Comparison

HAE currently leads LIVN in this stock comparison, with AIQ scores of 77 vs 71. The clearest difference is quality, while LIVN has the stronger risk resilience profile.

Market data as of Nov 18, 2026 market close· AIQ score gap 6 points
HAE
Healthcare
vs
LIVN
Healthcare
HAE
Haemonetics Corporation
Leads
Price
$123
Day move
+1.6%
AIQ Score
77/100
Best edge
Quality
Sector
Healthcare
LIVN
LivaNova PLC
Price
$94.54
Day move
+2.85%
AIQ Score
71/100
Best edge
Risk Resilience
Sector
Healthcare

What is the main difference between HAE and LIVN?

HAE leads the current stock comparison as Haemonetics Corporation, with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Haemonetics Corporation vs LivaNova PLC

Data as of Nov 18, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 4/10

HAE leads

HAE leads by 6 AIQ points, primarily on Quality and Momentum, but the lead has narrowed from 10 points over 30 sessions.

Fragile: 3 of 6 evidence groups support HAE, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 3 of 6Comparison trend: Weakening
HAE

Haemonetics Corporation

Leads
AIQ Score
77/100
AIQ Edge Score
10/10
LIVN

LivaNova PLC

AIQ Score
71/100
AIQ Edge Score
9/10

The Algovestiq AIQ Score currently favors HAE over LIVN, 77 versus 71 as of Nov 18, 2026. HAE's advantage is driven primarily by stronger quality and momentum, while LIVN holds the stronger risk resilience profile. HAE also shows the weaker technical structure relative to its 50-day moving average. 3 of 6 covered evidence groups favor HAE today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. HAE lead: Weakening — the AIQ differential moved from 10 to 6 points over 30 sessions.

Compare Haemonetics Corporation and LivaNova PLC across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

HAE
+122.9%
LIVN
+10.3%

Price return comparison

Growth of $10,000, price only

HAE $22,290 · LIVN $11,030

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare HAE and LIVN against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

HAE advantage
0
LIVN advantage
  • Quality77 vs 64
    HAE +13
  • Momentum91 vs 83
    HAE +8
  • Risk Resilience67 vs 71
    LIVN +4
  • Value60 vs 60
    Even

3 of 6 evidence groups favor HAE. HAE’s edge is concentrated in quality and momentum; LIVN keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.

HAE0 AIQ

Largest factor move: Momentum -1, not enough on its own to move the overall score.

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.64x)
LIVN0 AIQ

Largest factor move: Value -1, not enough on its own to move the overall score.

New signals

  • Keltner Channel Breakout — bullish, volatility, short horizon

HAE's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — HAE and LIVN both carry a full feed there.

The central trade-off

HAE (Haemonetics Corporation): the stronger current systematic profile, led by quality and momentum.

LIVN (LivaNova PLC): the counter-case, on risk resilience — but at materially higher volatility, 69.2% against 33.1%.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

HAE

HAE on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

HAE

HAE on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

HAE

HAE on the Momentum factor, by 8 points.

Lower downside

LIVN

LIVN on Risk Resilience, by 4 points.

Analyst upside

Even

Analyst targets are level or not covered for both names.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureHAELIVNNote
Implied upside to target+14.1%+13.7%Level
Target dispersion+32.8%+27.9%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1212Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor HAE. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreHAE77 vs 71
FundamentalsHAEon balanceEPS growth 39.7% vs -68.7%; TTM ROE 5.2% vs 2.5%; gross margin 58.8% vs 67.9%; operating margin 18.3% vs 11.5% — HAE takes 3 of 4 decided legs, not all of them
ValuationEvenValue 60 vs 60
TechnicalsHAEPrice vs 50-day 8.4% vs 17.7%; vs 200-day 51.3% vs 23.1%
Risk ResilienceLIVNRisk Resilience 67 vs 71
Analyst expectationsEvenTarget upside 14.1% vs 13.7%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of HAE and LIVN and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 6 points.
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on HAE.

How the comparison changed

120 daily snapshots · Jun 1 – Nov 18

HAE lead: Weakening — the AIQ differential moved from 10 to 6 points over 30 sessions.

Jun 1HAE leads above the line · LIVN leads belowNov 18
Today
HAE +6
77 vs 71
7 sessions ago
HAE +7
78 vs 71
30 sessions ago
HAE +10
78 vs 68
90 sessions ago
HAE +9
77 vs 68

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

HAEConflicted

3 bullish / 1 bearish / 2 neutral, conflicted

Only HAE

  • Low Volume Rally Warning — bearish, volume, short horizon (0.64x)
LIVN

5 bullish / 0 bearish / 2 neutral

Only LIVN

  • Keltner Channel Breakout — bullish, volatility, short horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon

Both carry 5 more signals that do not separate them: Golden Cross Active, ADX Trend Strengthening, ATR Expansion - Breakout Mode, EMA Ribbon Expansion Bullish, Uptrend Structure Active.

HAE leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

HAENo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.6%, AIQ 0 points).

LIVNNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +2.85%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1LIVN closes the Quality gap — currently 13 points behind, the largest single contributor to HAE's edge.
  2. 2LIVN generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover.
  3. 3HAE's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 4 points over 30 sessions, and a further 6-point move would eliminate HAE's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

HAE leads on balance
MetricHAELIVN
Revenue growth (YoY)5.4%0.6%
EPS growth (YoY)39.7%-68.7%
Gross margin58.8%67.9%
Operating margin18.3%11.5%
Return on equity (TTM)5.2%2.5%
Debt to equity1.250.25

Performance

HAE leads 5 of 6 windows
MetricHAELIVN
1 week (5 sessions)2.5%1.5%
1 month (20 sessions)3.9%17.7%
3 months (63 sessions)36.2%12.1%
6 months (126 sessions)118.4%30.5%
Year to date53.4%48.4%
1 year (252 sessions)68.1%61.3%

Technicals

HAE has the stronger structure
MetricHAELIVN
RSI (14)58.765.5
ADX (14)38.630.8
Price vs 50-day8.4%17.7%
Price vs 200-day51.3%23.1%
Volatility (1M, annualized)33.1%69.2%

Risk

LIVN is the more resilient
MetricHAELIVN
Beta0.241.09
Sharpe ratio1.351.38
Sortino ratio2.462.59
Max drawdown-40.1%-18.9%
Current drawdown-3.5%-3%
Annualized volatility41%39.2%
Value at risk (95%)-3.1%-2.9%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, HAE or LIVN?

On the Algovestiq AIQ Score, HAE is the stronger of the two as of Nov 18, 2026, scoring 77 against LIVN's 71. The edge comes from quality and momentum. LIVN is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is HAE or LIVN the better buy right now?

HAE carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.

Why does the AIQ Score favor HAE over LIVN?

The composite weights Quality, Value, Momentum and Risk Resilience. HAE leads Quality by 13 points; HAE leads Momentum by 8 points; LIVN leads Risk Resilience by 4 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, HAE or LIVN?

Analyst price targets imply +14.1% upside for HAE and +13.7% for LIVN. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, HAE or LIVN?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, HAE or LIVN?

HAE on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, HAE or LIVN?

HAE on the Momentum factor, by 8 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, HAE or LIVN?

LIVN is the more resilient of the two, so the other name carries the higher downside risk. LIVN on Risk Resilience, by 4 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is HAE more profitable than LIVN?

The profitability evidence is mixed: gross margin 58.8% vs 67.9%; operating margin 18.3% vs 11.5%; ttm roe 5.2% vs 2.5%. HAE leads on two measures and LIVN on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is HAE's lead over LIVN getting stronger or weaker?

HAE lead: Weakening — the AIQ differential moved from 10 to 6 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has not changed hands in that window.

What would change the HAE vs LIVN verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: LIVN closes the Quality gap — currently 13 points behind, the largest single contributor to HAE's edge; LIVN generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover; HAE's conflicting signal state resolves bearish — it currently carries 3 bullish and 1 bearish rules at once; the narrowing continues — the lead has already given back 4 points over 30 sessions, and a further 6-point move would eliminate HAE's advantage entirely.

What do the current signals say about HAE and LIVN?

HAE: 3 bullish / 1 bearish / 2 neutral, conflicted. LIVN: 5 bullish / 0 bearish / 2 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on HAE is Golden Cross Active (bullish, long horizon). On LIVN it is Golden Cross Active (bullish, long horizon).

Compare HAE and LIVN with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.